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Results and Discussion {#sec1}
======================

In *S. pombe*, cell-geometry, cell-wall, and cytokinesis-positioning factors contribute to the determination of the location of the actomyosin ring \[[@bib4], [@bib12], [@bib13], [@bib14], [@bib15]\]. To investigate where the actomyosin ring would form in the absence of all these factors (i.e., default position), we first generated spherical cells with minimal residual cell wall (spheroplasts) by enzymatically removing the cell wall in an osmotically stabilized environment. The isolated spheroplasts, which exhibited a rounded morphology, were typically cultured in medium containing 2-deoxyglucose, which is known to inhibit cell-wall assembly \[[@bib16], [@bib17], [@bib18]\].

To study the ring assembly process, we imaged wild-type spheroplasts expressing LifeAct-EGFP (as a proxy for actin filaments) and mCherry-Atb2 (alpha-tubulin; as a marker of the cell-cycle stage) in cell suspension using time-lapse microscopy \[[@bib19]\]. We measured and compared the ring diameters (Rs; visualized either by LifeAct-EGFP or Rlc1-GFP) to the spheroplast diameters (Ss). The diameter of the spheroplast (S) is defined as the length of a line through the center of the spheroplast that intersects two points on its circumference. The ratio of these parameters (R/S) was used to express the size of the assembled ring in relation to the diameter of the spheroplast ([Figure 1](#fig1){ref-type="fig"}A). The LifeAct-EGFP ([Figure S1](#mmc1){ref-type="supplementary-material"}) and Rlc1-GFP (regulatory light chain of myosin) \[[@bib20]\] used did not cause any overt cytokinetic phenotype in cells, and were therefore used in these studies.Figure 1Assembly of an Actomyosin Ring at the Equator in Wild-Type Spheroplasts(A) Sketch of diameters of the rings (Rs) and spheroplasts (Ss). R and S are measured and compared. The ratio of R/S is used to indicate the size of the newly assembled rings. When the ratio is close to 1, it indicates the equatorial positioning of a ring.(B) Time-lapse microscopic images of a wild-type spheroplast expressing LifeAct-EGFP (actin) and mCherry-Atb2 (tubulin). The R/S ratio of spheroplasts is quantitated and plotted (n = 116). See also [Movie S1](#mmc2){ref-type="supplementary-material"}.(C) Time-lapse microscopic images of a wild-type spheroplast expressing Rlc1-GFP (myosin) and mCherry-Atb2 (tubulin). The R/S ratio of spheroplasts is quantitated and plotted (n = 60).(D) Images of intact cells and spheroplasts expressing Mid1-GFP, Tea1-GFP, and mCherry-Atb2 (tubulin). Fluorescence intensities of Mid1-GFP and Tea1-GFP were measured along the cell perimeters, which revealed mislocalization of Mid1-GFP and Tea1-GFP in spheroplasts.Scale bars, 5 μm. Error bars indicate SD. See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

When spheroplasts progressed through mitosis, as indicated by the formation and elongation of the mitotic spindle, surprisingly the actin ring assembled at an equatorial position very close to the path of maximum circumference in 90% of the spheroplasts (an R/S of 0.85 was chosen as the cutoff for equatorial localization of the ring) (R/S ∼0.93 ± 0.08; [Figure 1](#fig1){ref-type="fig"}B; [Movie S1](#mmc2){ref-type="supplementary-material"}). These rings slid and disassembled eventually, as described in previous work \[[@bib12], [@bib21], [@bib22]\], although these studies did not investigate ring positioning in spheroplasts. Similarly, rings containing Rlc1-GFP also assembled at the equator of spheroplasts, indicating that actomyosin rings were assembled equatorially in wild-type spheroplasts (R/S ∼0.93 ± 0.09; [Figure 1](#fig1){ref-type="fig"}C). Despite the equatorial localization of the actomyosin ring in wild-type spheroplasts, Mid1 and Tea1, key components involved in division-site placement, were barely detectable and/or were scattered throughout the spheroplast plasma membrane ([Figure 1](#fig1){ref-type="fig"}D). By contrast, Mid1 and Tea1 localized normally in intact wild-type cells ([Figure 1](#fig1){ref-type="fig"}D).

Although Mid1 and Tea1 were either mislocalized or undetectable in wild-type spheroplasts, it was possible that slight enrichments that were not immediately apparent were causing equatorial assembly of actomyosin rings. We therefore first studied ring positioning in *mid1*-18 spheroplasts that were defective in Mid1 function. Interestingly, in *mid1*-18 spheroplasts at the restrictive temperature, the majority of the spheroplasts still assembled a ring at the equator, as in the wild-type spheroplasts. Roughly 90% of cells assembled equatorial actomyosin rings (R/S ∼0.93 ± 0.06; [Figure 2](#fig2){ref-type="fig"}A). We then tested the role of Tea1 in equatorial ring assembly and found that it also did not play a role in equatorial ring assembly (R/S ∼0.89 ± 0.12; [Figure 2](#fig2){ref-type="fig"}B). Finally, we investigated ring positioning in spheroplasts lacking both Mid1 and Tea1, and surprisingly found that ∼84% of these spheroplasts assembled equatorial actomyosin rings containing F-actin and Rlc1 (R/S ∼0.91 ± 0.08; [Figure 2](#fig2){ref-type="fig"}C; [Movie S2](#mmc3){ref-type="supplementary-material"}). Interestingly, the spheroplasts lacking Mid1 or Tea1 or both assembled rings at the later stage of mitosis, which is approximately 25--30 min after mitotic entry, as indicated by the formation of short mitotic spindles ([Figure S2](#mmc1){ref-type="supplementary-material"}A). There appeared to be no relationships between the axes of anaphase spindles and actomyosin rings, as we could observe a wide range of inclination angles between these two axes ranging from being parallel to being perpendicular to each other ([Figure S2](#mmc1){ref-type="supplementary-material"}B; n = 20 spheroplasts). The F-BAR protein Cdc15 was also detected in equatorial rings in *mid1*-18 *tea1*Δ spheroplasts (R/S 0.878 ± 0.14; [Figure 2](#fig2){ref-type="fig"}D). Given the equatorial localization of actomyosin rings in cells defective for *mid1* and *tea1*, we tested the localization of the upstream regulators SAD-kinase Cdr2 and DYRK family kinase Pom1 in spheroplasts defective for *mid1* and *tea1*. The Cdr2 kinase and Pom1 kinase were distributed throughout the cortex or were undetectable, but were not concentrated in any equatorial pattern ([Figures S2](#mmc1){ref-type="supplementary-material"}C and S2D). Thus, equatorial assembly of actomyosin rings in spheroplasts is independent of Mid1, Cdr2, Pom1, and Tea1 functions.Figure 2Equatorial Assembly of Actomyosin Rings in Spheroplasts Defective in *mid1* and *tea1* Functions(A) Time-lapse microscopic images of *mid1*-18 mutant spheroplasts expressing LifeAct-EGFP (actin) and mCherry-Atb2 (tubulin). The R/S ratio of spheroplasts is quantitated and plotted (n = 40).(B) Time-lapse microscopic images of *tea1*-deletion mutant spheroplasts expressing LifeAct-EGFP (actin) and mCherry-Atb2 (tubulin). The R/S ratio of spheroplasts is quantitated and plotted (n = 40).(C) Dynamics of F-actin (top) and Rlc1 (bottom) in *mid1*-18 *tea1*Δ spheroplasts. The R/S ratio of spheroplasts is quantitated and plotted (n = 37). See also [Movie S2](#mmc3){ref-type="supplementary-material"}.(D) Localization of Cdc15 (top) and Rlc1 (bottom) in *mid1*-18 *tea1*Δ spheroplasts. The R/S ratio of spheroplasts is quantitated and plotted (n = 44).Scale bars, 5 μm. Error bars indicate SD. See also [Figure S2](#mmc1){ref-type="supplementary-material"}.

Given that the two major actomyosin ring-positioning mechanisms were not involved in equatorial positioning of the cytokinetic actomyosin ring in spheroplasts, we sought to determine the mechanism that positioned the actomyosin ring at the equator in spheroplasts. Recent work by Ishiwata and colleagues has shown that F-actin-containing rings can assemble at equatorial positions in cell-sized water-in-oil droplets \[[@bib23]\]. They further proposed that actin filaments, which behave as a flexible polymer, assemble along the path of least curvature to minimize the elastic energy of actin filaments. Furthermore, these authors showed that pressing the water-in-oil droplets led to the formation of elongated actin rings that were formed perpendicular to the plane of compression, thereby again following the path of least curvature \[[@bib23]\].

We investigated whether a similar mechanism may be operating in fission yeast spheroplasts. If this were the case, treatment of spheroplasts with pharmacological agents that sever actin filaments should cause non-equatorial assembly of actomyosin rings, as shorter actin filaments may be capable of assembling into rings of higher curvature. Swinholide-A has been shown to be an actin filament-severing compound \[[@bib24], [@bib25]\]. We have recently developed a method to purify polymerization-competent *S. pombe* actin and human β-actin and used these actins to characterize the effects of swinholide-A ([Figure 3](#fig3){ref-type="fig"}A). Whereas actin filaments were readily observed when purified G-actin was mixed with DMSO, MgCl~2~, and ATP, such polymers were not observed when G-actin was mixed with swinholide-A, MgCl~2~, and ATP ([Figure 3](#fig3){ref-type="fig"}A). These observations suggested that swinholide-A either blocked polymerization of or caused severing of fission yeast and human actin. To specifically address whether swinholide-A severed actin filaments, we treated pre-assembled human actin filaments with swinholide-A. We observed severing of actin filaments when filaments in a flow chamber were treated with swinholide-A, but not when they were treated with the solvent, DMSO ([Figure 3](#fig3){ref-type="fig"}B; [Movie S3](#mmc4){ref-type="supplementary-material"}). These results established that swinholide-A caused actin filament severing.Figure 3Treatment of *mid1*-18 *tea1*Δ Spheroplasts with an Actin-Disrupting Compound, Swinholide-A, Affects Equatorial Actomyosin Ring Assembly(A) Purified *S. pombe* globular actin and *H. sapiens* beta-globular actin were incubated with DMSO or with 10 μM swinholide-A in the actin polymerization buffer and imaged by fluorescence microscopy.(B) Pre-assembled actin filaments were treated with DMSO or with 1 μM swinholide-A, and imaged by total internal reflection fluorescence (TIRF) microscopy. The lengths of actin filaments after treatments were measured and normalized to their initial lengths, and their relative values were plotted as a function of time (n = 6 actin bundles/filaments for each treatment). See also [Movie S3](#mmc4){ref-type="supplementary-material"}.(C) The *mid1*-18 *tea1*Δ spheroplasts expressing LifeAct-EGFP (actin) and mCherry-Atb2 (tubulin) were incubated with DMSO or with 10 μM swinholide-A. Top: DMSO control; middle: a ring assembled with a larger circumference; bottom: a ring assembled with a smaller circumference. See also [Movie S4](#mmc5){ref-type="supplementary-material"}.(D) Top: a distribution of the R/S ratios of spheroplasts incubated with DMSO (n = 62) or with 10 μM swinholide-A (n = 83). Bottom: comparison of the R/S ratios of *mid1*-18 *tea1*Δ spheroplasts incubated with DMSO (n = 62) or with 10 μM swinholide-A (n = 83) (^∗∗∗∗^p \< 0.0001).(E) The *mid1*-18 *tea1*Δ *cdc3*-124 spheroplasts expressing LifeAct-EGFP (actin) and mCherry-Atb2 (tubulin) were imaged at 33°C. Top: a ring assembled with a larger circumference; bottom: a ring assembled with a smaller circumference.(F) Top: a distribution of the R/S ratios of *mid1*-18 *tea1*Δ *cdc3*-124 spheroplasts (n = 22) and *mid1*-18 *tea1*Δ spheroplasts (n = 18). Bottom: comparison of the R/S ratios of *mid1*-18 *tea1*Δ *cdc3*-124 spheroplasts (n = 22) and *mid1*-18 *tea1*Δ spheroplasts (n = 18) (^∗∗∗∗^p \< 0.0001).Scale bars, 5 μm. Error bars indicate SD.

We then treated *mid1*-18 *tea1*Δ spheroplasts with swinholide-A or DMSO to assess the position of the actomyosin rings. DMSO-treated spheroplasts were similar to untreated spheroplasts and assembled equatorial actomyosin rings (R/S ∼0.86 ± 0.11; [Figure 3](#fig3){ref-type="fig"}C; [Movie S4](#mmc5){ref-type="supplementary-material"}). Interestingly, upon swinholide-A treatment, we found two classes of actomyosin rings. In ∼14% of spheroplasts treated with swinholide-A, actomyosin rings assembled at equatorial locations. However, in ∼86% of swinholide-A-treated spheroplasts, actomyosin rings assembled at non-equatorial locations and the average R/S ratio was ∼0.65 ± 0.18, with a large number of rings even showing an R/S ratio of 0.5 ([Figure 3](#fig3){ref-type="fig"}D). We also found that partially compromising the actin polymerization factor Cdc3-profilin in *mid1*-18 *tea1*Δ (by growing at the semi-restrictive temperature of 33°C) led to assembly of non-equatorial actomyosin rings with higher curvature ([Figure 3](#fig3){ref-type="fig"}E). In spheroplasts from *mid1*-18 *tea1*Δ *cdc3*-124, ∼87% of rings assembled non-equatorially with an R/S of ∼0.54 ± 0.23 ([Figure 3](#fig3){ref-type="fig"}F). It is likely that partial compromise of Cdc3-profilin slows down actin polymerization, resulting in shorter actin filaments, which then are organized into actomyosin rings with high curvature. Collectively, these experiments suggested that long actin filaments assembled in spheroplasts during actomyosin ring assembly follow the path of least curvature to minimize the elastic energy, whereas shorter actin filaments generated upon swinholide-A treatment or when Cdc3-profilin is partially compromised allowed assembly of non-equatorial actomyosin rings.

Our experiments have led to the suggestion that actomyosin rings follow a path of minimal curvature during assembly in spheroplasts lacking Mid1 and Tea1. If this were the case, compression of spheroplasts would be expected to cause ring assembly along the paths of least curvature, leading to ring assembly parallel to the imaging plane and perpendicular to the axis of compression. To test this prediction, we next compressed the *mid1*-18 *tea1*Δ spheroplasts mechanically between a coverslip and an agarose pad, as shown in the schematic in [Figure 4](#fig4){ref-type="fig"}A. Uncompressed spheroplasts assembled circular actomyosin rings of uniform curvature (uncompressed spheroplast panels, [Figure 4](#fig4){ref-type="fig"}B). Interestingly, 28 out of 28 compressed spheroplasts, upon entry into mitosis, assembled elongated actomyosin rings that were parallel to the imaging plane and perpendicular to the axis of compression, with large segments showing low local curvatures (compressed spheroplast panels, [Figure 4](#fig4){ref-type="fig"}B; [Movie S5](#mmc6){ref-type="supplementary-material"}). To test whether the adoption of the path of least curvature is a property of actomyosin rings in spheroplasts, we next imaged actomyosin rings in cylindrical *S. pombe mid1*-18 *tea1*Δ cells. These cells assembled obround actomyosin rings that spanned the entire length of the cell ([Figure 4](#fig4){ref-type="fig"}C). This experiment established that even in cylindrical cells, loss of actomyosin ring-positioning factors led to ring assembly along the path of least curvature. This experiment also established that the assembly of actomyosin rings parallel to the imaging plane in compressed spheroplasts was not a result of the compression itself. Rather, the assembly of elongated actomyosin rings parallel to the imaging plane is due to the altered morphology of the spheroplasts.Figure 4Assembly of Actomyosin Rings in Compressed *mid1*-18 *tea1*Δ Spheroplasts(A) A diagram illustrating an overview of the compression of spheroplasts by sandwiching and pressing spheroplasts between a coverslip and an agarose pad.(B) Assembly of rings at the larger cell circumference in compressed *mid1*-18 *tea1*Δ spheroplasts. The top two panels are uncompressed spheroplasts (n = 37). The bottom three panels are compressed spheroplasts (n = 28). Curvatures of the ring and spheroplast circumferences are colored coded with the rainbow look-up table. For the uncompressed spheroplasts, the image was rotated so that the ring was parallel to the imaging plane for curvature measurement. The projection axes of the displayed images are indicated by the arrows labeled with x-y-z. The two diagrams illustrate the imaging axes. AM, actomyosin ring. See also [Movie S5](#mmc6){ref-type="supplementary-material"}.(C) Actin dynamics in *mid1*-18 *tea1*Δ cells expressing LifeAct-EGFP and mCherry-Atb2. Two examples are shown.Scale bars, 5 μm.

Positioning of the actomyosin ring is regulated by multiple mechanisms, which ensure proper spatial coordination with genome segregation \[[@bib26]\]. In this study, we removed the currently known cellular factors (such as cell morphology, cell wall, and two molecular positioning cues) that influence actomyosin ring positioning in *S. pombe* and asked where and how the ring was positioned in this system. Interestingly, without the influence of these cellular factors, the actomyosin ring assembled in an equatorial location along a path of least curvature. Our observations are consistent with findings of actin organization in water-in-oil droplets by Ishiwata and colleagues \[[@bib23]\]. Furthermore, these findings are complementary to our previous work in which we have shown that the increased curvature of the actomyosin ring, gained through ring contraction, promoted its disassembly \[[@bib22]\].

Actin filaments have a persistence length of \>10 μm \[[@bib27]\]. Given that actomyosin rings in *S. pombe* cells are composed of actin filaments ∼600 nm in length \[[@bib28], [@bib29]\], such smaller filaments may become easily packed along the short axis in wild-type cells. It is possible that Mid1 and/or cortical nodes not only ensure medial assembly of actin filaments \[[@bib9]\] but also play a role in ensuring that actin filaments remain short such that they can be organized along the short axis of the cell. In the *mid1* mutant cells, and in wild-type and *mid1* mutant spheroplasts, it is possible that actin filaments are longer, causing them to organize spontaneously along the equator in a path of least curvature. Consistent with this hypothesis, we have found that generation of smaller actin filaments using pharmacological means promotes non-equatorial ring assembly in spheroplasts, as shorter actin filaments may become easily packed in smaller and more curved actomyosin rings.

In summary, our work leads to the hypothesis that the default position of the cytokinetic actomyosin ring follows the path of least curvature and that Mid1 and/or cortical nodes may play a role in restricting the size of actin filaments. How Mid1 and/or the cortical nodes regulate actin filament-length homeostasis will be a fascinating question to investigate in the future.

STAR★Methods {#sec2}
============

Key Resources Table {#sec2.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Chemicals, Peptides, and Recombinant Proteins**Swinholide-AEnzo Life SciencesBML-T125-0020Phalloidin-biotinInvitrogenBiotin-XX Phalloidin B-7474Alexa Fluor 488-C5-maleimideThermo Fisher ScientificA10254Rhodamine-phalloidinLife TechnologiesR415LongLife ZymolyaseG-Biosciences786-914Lysing enzyme from *Trichoderma harzianum*SigmaL14122-deoxyglucoseSigmaD6134Hellmanex IIISigmaZ805939AvidinSigmaA3275**Experimental Models: Organisms/Strains***clp1::ura4+ ura4-D18 leu1-32 ade6-21* h+Laboratory collectionMBY977*mid1*-GFP*:ura4+* mCherry-*atb2:hph*Laboratory collectionMBY6462P*act1*-*lifeact*-EGFP:leu1+ mCherry*-atb2:hph ura4-D18 leu1-32* h-Laboratory collectionMBY6659P*act1*-*lifeact-*EGFP:*leu1+* mCherry-*atb2:hph ura4*-D18 *leu1*-32 h+Laboratory collectionMBY7114*mid1*-18 P*act1*-*lifeact-*EGFP:*leu1+* mCherry-*atb2:hph leu1*-32Laboratory collectionMBY7161*mid1*-18 *tea1::ura4+ rlc1*-tdTomato-*natMX6* h+This studyMBY10473*mid1*-18 *tea1::ura4+* P*act1*-*lifeact-*EGFP:*leu1+* mCherry-*atb2::hph* h-This studyMBY10921*mid1*-18 *tea1::ura4+* mEGFP*-cdc15:kanMX rlc1*-tdTomato-*natMX6* h+This studyMBY10989*tea1-*GFP:*KanMX6* mCherry-*atb2:Hph* h+This studyMBY11194*rlc1-*GFP:*leu1+* mCherry*-atb2:Hph* h+This studyMBY11200*tea1::ura4+* P*act1*-*lifeact-*EGFP:*leu1+* mCherry*-atb2:Hph* h-This studyMBY11255*clp1::ura4+* P*act1*-*lifeact-*EGFP:*leu1+* mCherry*-atb2:Hph* h-This studyMBY11627*tea1::ura4+ mid1*-18 *pom1-*GFP*:KanMX6* mCherry-*atb2:hph* h+This studyMBY11646*tea1::ura4+ mid1-*18 *cdc3-*124 P*act1*-*lifeact-*EGFP:*leu1+* mCherry*-atb2:Hph* h-This studyMBY11658*tea1::ura4+ mid1*-18 *cdr2*-GFP*:ura4+* mCherry-*atb2:hph* h-This studyMBY11666**Software and Algorithms**Prism 6.0GraphPadVersion 6.0**Other**μ-Slide 8-Well glass bottom dishIbidi80827

Contact for Reagent and Resource Sharing {#sec2.2}
----------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Mohan Balasubramanian (<m.k.balasubramanian@warwick.ac.uk>).

Experimental Model and Subject Details {#sec2.3}
--------------------------------------

### Yeast strains, medium, and culture conditions {#sec2.3.1}

*S. pombe* strains used are listed in the [Key Resources Table](#sec2.1){ref-type="sec"}. Strains were prepared by using standard fission yeast genetic techniques. Cells were cultured in rich medium YEA (5 g/L yeast extract, 30 g/L glucose, 225 mg/L adenine) until mid-log phase at 24°C for physiological analysis. Swinholide-A (Enzo Life Sciences; BML-T125-0020) was dissolved in DMSO and used at the final concentration of 10 μM in culture medium to perturb the actin cytoskeleton in spheroplasts.

### Preparation of *S. pombe* spheroplasts {#sec2.3.2}

All cells used in this study were first cultured in YEA medium at 24°C to mid-log phase (OD~595~ = 0.2-0.5), and then were shifted to 36°C for 2 hr. About 20 mL of culture were spun down at 3,000 rpm for 1 min, and washed once with equal volume of E-buffer (50 mM sodium citrate, 100 mM sodium phosphate, \[pH 6.0\]). The cells were spun down and resuspended in 5 mL of E-buffer containing 1.2 M sorbitol. The cell suspension was incubated with 30 mg of lysing enzyme from Trichoderma harzianum containing mixtures of cell wall lytic enzymes (Sigma, L1412) at 36°C with shaking at 80 rpm for 90 min. This was followed by continuous incubation with 40 μL of LongLife Zymolyase containing β-1,3-glucanase (G-Biosciences, 1.5 U/μL) at 36°C with shaking at 80 rpm for 60 min. The cells after enzymatic digestion were spun down at 450 xg for 2 min, and washed once with 5 mL of E-buffer containing 0.6 M sorbitol. The spheroplasts were spun down at 450 xg for 2 min, and recovered in 10 mL YES medium (YEA medium with all amino acids and nucleotides supplements) containing 0.8 M sorbitol and 0.5% (v/v) of 1 M 2-deoxyglucose (Sigma, D6134) for 30 min at 36°C before microscopy imaging. The *mid1*-18 *tea1*Δ *cdc3*-124 cells in [Figure 3](#fig3){ref-type="fig"}E were prepared similarly except using an incubation temperature of 33°C.

Method Details {#sec2.4}
--------------

### SD confocal microscopy and TIRF microscopy {#sec2.4.1}

All imaging of spheroplasts and cells (including wild-type) were done using the Andor Revolution XD spinning disk confocal microscope. Imaging for all figures except those in [Figures 3](#fig3){ref-type="fig"}B and 3E were done at 36°C to heat-inactivate the Mid1-18 function. The spinning-disk confocal system was equipped with the Nikon ECLIPSE Ti inverted microscope, Nikon Plan Apo Lambda 100 × /1.45 NA oil immersion objective lens, a spinning-disk system (CSU-X1; Yokogawa), and an Andor iXon Ultra EMCCD camera. Images were acquired using the Andor IQ3 software at the pixel size of 69 nm/pixel except in [Figure 2](#fig2){ref-type="fig"}D, which was at the pixel size of 80 nm/pixel. To illuminate the fluorophores, Laser lines at wavelengths of 488 nm or 561 nm were used for the excitation. All images in the time-lapse spinning-disk confocal microscopy were acquired with Z-step sizes of 0.5 μm.

The Andor Revolution TIRF system was equipped with the inverted Nikon Eclipse microscope base, Nikon Apo 100x/1.49 NA Apo TIRF objective lens, a motorized single line Nikon TIRF module, a 60 mW 488 nm solid state Laser and an Andor Zyla sCMOS camera. Images were acquired using Andor IQ3 software at the pixel size of 65 nm/pixel. The TIRF microscopy was done at room temperature.

### Sample preparation for live-cell imaging {#sec2.4.2}

To image the spheroplasts, 1-2 mL of suspension were concentrated to 20-100 μL by centrifugation at 450 xg for 2 min. About 10 μL of concentrated spheroplasts were loaded onto an Ibidi μ-Slide 8-Well glass bottom dish (Cat. No. 80827), and covered with mineral oil (Sigma, M5310) to prevent evaporation.

For swinholide-A treatment of spheroplasts in [Figure 3](#fig3){ref-type="fig"}C, spheroplasts after 30 min incubation in YES medium containing 0.8 M sorbitol and 2-deoxyglucose, were added with swinholide-A to a final concentration of 10 μM, and were imaged.

To image the compressed spheroplasts in [Figure 4](#fig4){ref-type="fig"}B and 1 μL of concentrated spheroplasts were sandwiched and compressed between a coverslip and a slide containing an agarose pad (YEA medium, 0.8 M sorbitol, 0.5% 2-deoxyglucose, 2% agarose). The slide was then sealed with VALAP (a mixture of Vaseline, lanolin and paraffin) prior to imaging.

### Purification of human and yeast actin {#sec2.4.3}

Recombinant globular actin from human (β-actin) and fission yeast (Act1) was prepared by expression using a strategy described in Noguchi et al. \[[@bib30]\], except that the methylotrophic yeast *Pichia pastoris* was used as a host for protein expression. After cell breakage, the lysates were processed similarly as described in Noguchi et al. \[[@bib30]\].

### Preparation of fluorescently-labeled actin {#sec2.4.4}

To fluorescently label the human β−actin used in [Figures 3](#fig3){ref-type="fig"}A and 3B, recombinant human globular β−actin (∼1.3 mg/mL) was polymerized in a buffer containing 2 mM MgCl~2~ and 100 mM KCl. The Alexa Fluor 488-C5-maleimide (Thermo Fisher Scientific, \#A10254) dissolved in dimethyl sulfoxide (3 mM stock) was added to reach a 3.5 molar excess of dye to G-actin, and incubated for 1 hr at room temperature. The reaction was quenched with 10 mM DTT. F-actin was pelleted by using ultracentrifugation (Beckman TLA-55 rotor) at room temperature at 45000 rpm for 1 hr. The pellet was re-suspended and dialyzed against G-buffer to depolymerize actin. The free Alexa Fluor 488-maleimide was separated from labeled actin using Sephadex G-25 (GE Healthcare, PD MidiTrap G-25, \#28-9180-07).

### Actin polymerization assays {#sec2.4.5}

For human β-actin polymerization assay, 10 μL reaction mixture containing 2 μL G-buffer, 5 μL of 1 μM AlexaFluor 488-conjugated purified actin, 2 μL of 50 μM swinholide-A (or comparable volume of DMSO), 1 μL of 10x MKE were prepared.

For *S. pombe* actin polymerization assay, 10 μL reaction mixture containing 4.5 μL G-buffer, 2.5 μL of purified actin, 2 μL of 50 μM swinholide-A (or comparable volume of DMSO), 1 μL of 10x MKE were prepared.

The reaction mixtures were incubated at room temperature for at least 30 min. A further 0.5 μL of Rhodamine-phalloidin (Life Technologies, R415) was added to the reaction mixture containing *S. pombe* actin prior to imaging. One microliter of reaction mixture was sandwiched between a coverslip and a slide, and imaged using the spinning-disk confocal microscope at room temperature.

### Analyses of F-actin severing by Swinholide A {#sec2.4.6}

Coverslips of two different sizes (40 × 22 mm and 20 × 20 mm; \#1.5, Scientific Lab Supplies) were cleaned by washing in 2% (v/v) solution of Hellmanex III (Sigma, Z805939) for 30 min at 60°C, and then were rinsed three times with water and blow-dried with dry nitrogen gas. To make a flow chamber, two clean coverslips of different sizes were sandwiched together using double sided tapes (Nichiban 90 μm). The flow chambers were treated with mixtures of PLL-PEG (SuSoS PLL(20)-g\[3.5\]-PEG(2)) and PLL-PEG/PLL-PEG-Biotin (SuSoS PLL(20)-g\[3.5\]-PEG(2)/PEG(3.4)biotin20%) with final concentration of PEG-Biotin at 0.5% in HEPES Rehydration buffer (HRB, 20 mM HEPES \[pH 7.1\], 150 mM NaCl) for 1 hr at room temperature. Unbound PLL-PEG were washed twice with 20 μL of HRB. The flow chambers were perfused with 0.17 mg/mL Avidin (Sigma A3275; resuspended in HRB) and incubated for 30 min at room temperature.

Alexa Fluour-488-labeled human beta G-actin was mixed with unlabeled G-actin to a final labeling ratio of 10%, and then supplemented with Magnesium exchange buffer (100 mM Imidazole \[pH 7.0\], 50 mM MgCl~2~, 2 mM EGTA, 1 M KCl), and incubated on ice for 5 min. Actin polymerization was induced at room temperature for 15 min in polymerization buffer (20 μM labeled G-actin, 0.2 mM ATP, 0.5 mM DTT, 10 mM Imidazole \[pH 7.0\], 1 mM MgCl~2~, 1 mM EGTA, 50 mM KCl). Biotinylation of F-actin was achieved by incubating F-actin with Phalloidin-biotin (Invitrogen, Biotin-XX Phalloidin B-7474) to a final concentration of 200 nM for 10 min.

Prior to TIRF microscopy analyses, an aliquot of biotinylated F-actin was diluted with polymerization buffer to a final concentration of 50 nM, and perfused into the flow chambers. After incubation at room temperature for 10 min, the flow chambers were subjected to TIRF microscopy analyses. Excess F-actin were washed with one volume of HRB. For chemical compound treatments in [Figure 3](#fig3){ref-type="fig"}B and 1 μM Swinholide-A (Enzo BML-T125-0020) in HRB was used. DMSO was used in the equivalent volume as Swinholide-A as a control treatment.

### Image analysis {#sec2.4.7}

Images were analyzed using Fiji. All image stacks except those in [Figures 3](#fig3){ref-type="fig"}A and 3B were projected along the Z axis (maximum intensity) for analysis and for representation. To measure the protein fluorescence intensities in [Figure 1](#fig1){ref-type="fig"}D, image stacks were projected along the Z axis (sum intensity) for quantification. The background of all microscopy images was subtracted in Fiji (Fiji/Process/Subtract Background). All time-lapse microscopy images were corrected for photo-bleaching in Fiji (Fiji/Image/Adjust/Bleach Correction).

To measure the R/S ratios, the longest diameter of the rings (indicated by Rlc1 or LifeAct fusion proteins) and the longest diameter of the spheroplasts were measured using the segmented line and measurements tools of Fiji. The shapes of the spheroplasts and the newly assembled rings were verified to be of a round shape by looking at the 3D projection (Fiji/Image/Stacks/3D project) of the spheroplasts and rings.

Quantification and Statistical Analysis {#sec2.5}
---------------------------------------

Statistical significance was determined using Student's t test in [Figures 3](#fig3){ref-type="fig"}D and 3F. Calculations of mean, standard deviation (s.d.), and statistical significances, were done using Prism 6.0 (GraphPad).
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